omsaipharma777@gmail.com
Change Language
Carfilnat Carfilzomib Injection

Carfilnat Carfilzomib Injection

12488 INR/Box

Product Details:

  • Ingredients Other
  • Application Other
  • Fermentation Smell Slight Smell
  • Storage Instructions Cold & Dry
  • Click to View more
X

Carfilnat Carfilzomib Injection Price And Quantity

  • 12488 INR/Box
  • 10 Box

Carfilnat Carfilzomib Injection Product Specifications

  • Other
  • Slight Smell
  • Cold & Dry
  • Other

Carfilnat Carfilzomib Injection Trade Information

  • Central America Asia Australia North America South America Middle East Eastern Europe Western Europe Africa
  • All India

Product Description

Carfilzomib injection is a medication used to treat multiple myeloma, a type of blood cancer that affects plasma cells. It belongs to a class of drugs called proteasome inhibitors, which work by blocking the action of proteasomes, which are enzymes that break down proteins in cells.

The medication is given as an injection into a vein (intravenously) by a healthcare professional. The injection may be given once or twice a week, depending on the dosing schedule prescribed by the healthcare provider.

Carfilzomib injection may cause some side effects, including nausea, vomiting, diarrhea, fatigue, fever, and decreased appetite. It may also cause more serious side effects, such as low blood cell counts or heart problems. If you experience any severe or persistent side effects, be sure to contact your doctor or healthcare provider.

As with any cancer medication, carfilzomib injection may not be suitable for everyone. It is important to discuss any medical conditions, allergies, or other medications you may be taking with your healthcare provider before starting treatment. It is also important to inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as the medication may harm an unborn or nursing baby.



Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anti Cancer Medicine' category



Back to top